Skip to main content

Lifecore Biomedical, Inc.

LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001005286

No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Lifecore Biomedical, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of LFCR: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders9897−1
Shares25.9M25.7M−201.7K (−0.8%)
Value$287.2M$278.9M−$8.23M (−2.9%)

New holders (11)

Institutions that held Lifecore Biomedical, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to LFCR in Q1 2022
InstitutionSharesValue% of portfolio
Parkman Healthcare Partners LLC115,316$1.33M0.39%
Citadel Advisors LLC45,860$531.0K0.00%
Susquehanna International Group, LLP10,092$117.0K0.00%
Cubist Systematic Strategies, LLC9,323$108.0K0.00%
Amalgamated Bank3,163$37.0K0.00%
Amalgamated Financial Corp.3,163$37.0K0.00%
FMR LLC1,259$15.0K0.00%
US Bancorp251$3.00K0.00%
Aquatic Capital Management LLC300$3.00K0.00%
CWM, LLC78$1.00K0.00%
Lindbrook Capital, LLC65$1.00K0.00%

Sold out (12)

Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of LFCR in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Kennedy Capital Management, Inc.704,722$7.82M
William Blair Investment Management, LLC401,638$4.46M
Davy Global Fund Management Ltd255,126$2.83M
Ameriprise Financial Inc33,413$371.0K
HRT Financial LP30,997$344.0K
Perritt Capital Management Inc26,750$297.0K
Squarepoint Ops LLC15,349$170.0K
Trexquant Investment LP12,624$140.0K
Jump Financial, LLC10,756$119.0K
Lazard Asset Management LLC6,655$73.0K
Confluence Wealth Services, Inc.1,745$19.0K
Marshall Wace, LLP104$1.00K